DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Abbott Laboratories

ABTNYSE$103.70+$1.19 (+1.16%)Market closed

Price Chart

Daily

Key facts

Market Cap
$180.48B
P/E
27.6x
P/B
3.45x
ROE
13.1%

Abbott Laboratories

Healthcare · Medical Devices · FY 2025

Abbott Laboratories, a globally renowned company, specializes in the development and production of healthcare and medical products. Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a pivotal entity in the healthcare sector. The company provides essential products spanning diagnostics, medical devices, nutritional products, and branded generic pharmaceuticals. Notably, Abbott's extensive diagnostic solutions include immunoassays and molecular diagnostics, crucial for medical testing and healthcare management. Its medical devices division produces cardiovascular and neuromodulation products, enhancing patient care across diverse medical practices. Abbott’s nutritional segment, featuring well-known brands like Similac and Ensure, supports health and wellness across various demographics. Serving markets globally, Abbott Laboratories plays a critical role in advancing healthcare infrastructure and delivering innovative solutions that address evolving health challenges worldwide. As a significant player in the life sciences field, Abbott's contributions significantly influence patient outcomes and healthcare delivery systems.

CEO
Mr. Robert B. Ford
Employees
114,000
Website
abbott.com

Company Statistics

Valuation

P/E
27.6x
P/B
3.45x
P/S
4.06x
EV/EBITDA
15.5x
P/FCF
24.4x

Margins

Gross
56.4%
EBITDA
27.1%
Operating
18.2%
Pre-Tax
19.1%
Net
14.7%

Returns

ROA
7.8%
ROE
13.1%
ROIC
10.7%

Growth (CAGR)

Rev 3Yr
0.5%
Rev 5Yr
5.1%
Op Inc 3Yr
−1.2%
Net Inc 3Yr
−2.0%

Financial Health

Cash & Cash Equivalents
$8.52B
Net Debt
$25.42B
Debt/Equity
64.3%
Interest Cov
—

Profile

Revenue
$44.33B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Abbott Laboratories (ABT) Stock Forecast 2026 $103.70 — Price, Financials & Analyst Targets | AlphaLenz